Table 5.
An overview of C. elegans populations sorted by microfluidic devices.
| Target sorting population(s) | Capabilities | Reference(s) |
|---|---|---|
| Eggs (embryos) | Embryonic gene expression and morphogenesis | [38,46,49,93,113,116,117,162] |
| L1 larvae | Late embryonic development and other studies of developmental processes | [32,118] |
| L3 to L4 larvae | Genetics research with higher sample purity, test of size effect on the sorting effectiveness | [120] |
| L2 to L4 larvae | Simultaneous synchronization of massive different stages of worms for relevant studies | [55] |
| L1 to L4 larvae | Long-term and continuous larval phenotype observation and population acquisition | [46,121] |
| Adults of different ages | Neurodegenerative disease and aging research | [24,54,55,61] |
| All stages including adults | Biochemistry, disease, genetics, and more | [20–22,47–49,51,75,110] |
| Mutants from wild type | Mutation studies and drug discovery | [20,24,48,49,55,74,112,122,134,135] |